Berlingske

The time when the Novo Nordisk Foundation allocated 90 percent of its billion-sized distributions in Denmark, while 99 percent of the money flowed in from sales and investments in other countries, is over. From now on, the majority of the foundation’s expected growth in distributions will take place outside of Denmark.